consumer protection

CDC Health Advisory: Severe Pulmonary Disease Associated with Using E-Cigarette Products

2019-09-04T09:34:15-05:00September 4th, 2019|Pharmacists, Public/Community Health, Smoking Cessation|

Distributed via the CDC Health Alert Network August 30, 2019, 0935 AM ET (9:35 AM ET) CDCHAN-00421 Summary The Centers for Disease Control and Prevention (CDC) is providing: 1) background information on the forms of e-cigarette products, 2) information on the multistate outbreak of severe pulmonary disease associated with using e-cigarette products (devices, liquids, refill [...]

FDA Public Hearing, May 31, 2019: Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds

2019-05-08T14:29:08-05:00May 8th, 2019|Marijuana|

FDA Public Hearing: Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, May 31, 2019 The Food and Drug Administration has announced a public hearing to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds. The public [...]

California Pharmacists Opioid Safety Training

2017-02-13T22:54:11-06:00February 13th, 2017|Naloxone, Opioid Epidemic, Opioid Safety, Pharmaceutical TakeBack, Pharmacist Training, Pharmacists|

California Pharmacists Opioid Safety Training The Last Line of Defense in the Healthcare Team More than 2,000 people in California die every year from overdoses related to opioids. Pharmacists are literally the last line of defense in the healthcare team. Register below for this one-hour CME class for pharmacists on safe dispensing of opioid medications. [...]

Send a letter re overpriced Naloxone!!!!

2016-09-18T19:14:02-05:00September 18th, 2016|Naloxone|

Dear PPSI followers: Please send your letter, SAMPLE BELOW AND LINK HERE> hmo-insurances-ltr-re-naloxone, to as many of the insurance companies possible-with your name, phone number and email. HMO addresses and emails obtained via HICAP (California based) (insert sample insurance company PO Box xxxx anytown, any-state, correct zip) Dear Medical Director: I am writing to you, as _______ and as _________ regarding [...]

First pre-regulatory stakeholder meetings w/ Bureau of Medical Cannabis Regulation-Sept & Oct

2016-09-12T19:03:12-05:00September 12th, 2016|Medical Cannabis, Pharmacists|

The Bureau of Medical Cannabis Regulation (BMCR) and Office of Medical Cannabis Safety (OMCS) will be holding their first pre-regulatory stakeholder meetings this September and October. Discussing issues related to general licensing requirements, and specific concepts related to the regulation of medical cannabis dispensaries, distributors, manufacturers, testing laboratories and transporters. Please join us for one of [...]

Office of Medical Cannabis Safety-SAVE THE DATE! Pre-Regulatory Meetings.

2016-08-26T03:01:56-05:00August 26th, 2016|Medical Cannabis, Pharmacists|

PPSI would like to testify in Santa Rosa on September 22, from 2-3 PM PPSI would like to testify on determining standards for packaging, labeling, dosing, potency of medical cannabis, produced as medicine, food, botanical and edibles, labeling, dosing, package contents, public health safety warnings, safety standards, cautions and public;  (to mental and physical health [...]

Join PPSI!!!

2016-04-21T03:13:27-05:00April 21st, 2016|Pharmacists|

Welcome to our updated and renovated website. We are excited as we move forward with continued advocacy, so much exciting happening, the world needs serious PRO-action! Our work going forward is vital as we address issues such as Medical Cannabis; Product labeling, dosing, safety warnings, and combating violations of solid consumer dispensing regulations as we [...]

Go to Top